JPM 2026: From "Recovery" to "Execution"
The "growth at all costs" era is officially dead. The vibe at the 44th Annual J.P. Morgan Healthcare Conference was one of cautious optimism. The industry has pivoted from scrambling for procedure volume recovery to a disciplined focus on operating margins, supply chain stability, and execution.
If 2025 was about stabilization, 2026 is about the "Boring Breakthrough"—where success isn't defined by sci-fi concepts, but by workflow efficiency and profitability.
The Big 3 Trends
1. The "Agentic AI" Era We’ve moved past AI that merely analyzes data to AI th...
